| P50 | author | Stanley I. Rapoport | Q57269588 |
| P2093 | author name string | Jagadeesh S Rao | |
| P2860 | cites work | Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. | Q52021373 |
| | Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. | Q52035778 |
| | Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. | Q53573170 |
| | Kinetics of lipopolysaccharide-induced transcription factor activation/inactivation and relation to proinflammatory gene expression in the murine spleen. | Q53976702 |
| | CSF Prostaglandin Levels in Depressed and Schizophrenic Patients | Q57616641 |
| | The effects of valproate on the arachidonic acid metabolism of rat brain microvessels and of platelets | Q60732982 |
| | Effects of chronic lithium treatment on agonist-enhanced extracellular concentrations of cyclic AMP in the dorsal hippocampus of freely moving rats | Q72334790 |
| | Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme | Q72621635 |
| | Evidence that Lithium Alters Phosphoinositide Metabolism: Chronic Administration Elevates Primarily d-myo-Inositol-1-Phosphate in Cerebral Cortex of the Rat | Q72895389 |
| | Distribution of cytoplasmic phospholipase A2 in the normal rat brain | Q73120399 |
| | Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: a preliminary study | Q74238364 |
| | Involvement of group VI Ca2+-independent phospholipase A2 in protein kinase C-dependent arachidonic acid liberation in zymosan-stimulated macrophage-like P388D1 cells | Q77955228 |
| | Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder | Q77965869 |
| | Bipolar disorder | Q80392074 |
| | Affective Disorders and Suicide Risk: A Reexamination | Q22306288 |
| | A molecular mechanism for the effect of lithium on development | Q24629067 |
| | The neurobiological bases for development of pharmacological treatments of aggressive disorders | Q24651612 |
| | A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder | Q24655759 |
| | The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system | Q24812038 |
| | Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology | Q28142758 |
| | Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial | Q28143204 |
| | Prostaglandins and leukotrienes: advances in eicosanoid biology | Q28208246 |
| | 5'-flanking region surrounding a human cytosolic phospholipase A2 gene | Q28243063 |
| | Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A | Q28273256 |
| | The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 | Q28565225 |
| | Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain | Q28575972 |
| | Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex | Q28581107 |
| | 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain | Q28582202 |
| | Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen | Q29616224 |
| | Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics | Q30742006 |
| | New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder | Q30985990 |
| | Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels | Q31871077 |
| | Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants | Q33596978 |
| | Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta | Q44864736 |
| | Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain | Q45019398 |
| | NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder | Q45098872 |
| | The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders | Q45142531 |
| | Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania | Q45243903 |
| | An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression | Q45260842 |
| | Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism | Q45272338 |
| | Salivary prostaglandin concentrations: possible state indicators for major depression | Q46191091 |
| | Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid | Q46423984 |
| | Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. | Q46573427 |
| | Transcription of the NR1 subunit of the N-methyl-D-aspartate receptor is down-regulated by excitotoxic stimulation and cerebral ischemia. | Q46622444 |
| | Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder | Q46718992 |
| | Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats | Q46808102 |
| | Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. | Q46934944 |
| | Effects of lithium on cAMP-dependent protein kinase in rat brain | Q47883089 |
| | Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family | Q48070462 |
| | Association of genetic differences in social behavior and cellular immune responsiveness: effects of social experience | Q48110731 |
| | Effects of LPS on the behavioural stress response of genetically selected aggressive and nonaggressive wild house mice | Q48111834 |
| | Increased levels of glutamate in brains from patients with mood disorders. | Q48133783 |
| | Effects of lithium on receptor-mediated activation of G proteins in rat brain cortical membranes | Q48224899 |
| | Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment | Q48228803 |
| | Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. | Q48273349 |
| | Actions of lithium on the cyclic AMP signalling system in various regions of the brain--possible relations to its psychotropic actions. A study on the adenylate cyclase in rat cerebral cortex, corpus striatum and hippocampus | Q48384116 |
| | Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder | Q48397179 |
| | Selective effects of long-term lithium and carbamazepine administration on G-protein subunit expression in rat brain | Q48529419 |
| | Serum calcium-independent phospholipase A2 activity in bipolar affective disorder | Q48542693 |
| | Chronic lithium administration alters a prominent PKC substrate in rat hippocampus | Q48546705 |
| | N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels | Q48611711 |
| | Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals | Q48655158 |
| | Increase in AP-1 transcription factor DNA binding activity by valproic acid | Q48773462 |
| | Lithium decreases turnover of arachidonate in several brain phospholipids | Q48828317 |
| | Frontal lobe gray matter density decreases in bipolar I disorder. | Q51006334 |
| | Elevated levels of prostaglandin E2 and thromboxane B2 in depression. | Q51242532 |
| | Regional cerebral cortical thinning in bipolar disorder. | Q51955945 |
| | A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 |
| | Cyclo-oxygenase isoenzymes: physiological and pharmacological role | Q33904336 |
| | Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells | Q33924323 |
| | The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases | Q33963449 |
| | Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. | Q34484162 |
| | Phospholipase A2. | Q34548389 |
| | PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers | Q34622380 |
| | Cell pathology in bipolar disorder | Q34692741 |
| | Evidence for a role of the arachidonic acid cascade in affective disorders: a review | Q35684403 |
| | Valproate in the treatment of bipolar disorder: literature review and clinical guidelines | Q35899195 |
| | Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole | Q35944981 |
| | Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain | Q36253556 |
| | Improving physical quality of life with group physical activity in the adjunctive treatment of major depressive disorder | Q36493945 |
| | The neurobiology of aggression and rage: role of cytokines | Q36579992 |
| | Structure of the human cyclo-oxygenase-2 gene | Q36725123 |
| | Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation | Q36953315 |
| | The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth | Q38299684 |
| | Are disturbances in lipid-protein interactions by phospholipase-A2 a predisposing factor in affective illness? | Q38348567 |
| | Eicosanoids in the central nervous system | Q39497312 |
| | Mediation of inflammation by cyclooxygenase-2. | Q40444145 |
| | Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. | Q40957789 |
| | The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. | Q40970988 |
| | Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways | Q40978833 |
| | Attenuation of cyclic AMP production by carbamazepine. | Q41156836 |
| | Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation | Q41180647 |
| | Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials | Q42164457 |
| | Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat. | Q42459019 |
| | Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats | Q42473160 |
| | In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. | Q42522403 |
| | Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder | Q42604899 |
| | A pilot study of topiramate as monotherapy in the treatment of acute mania | Q42651172 |
| | Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain | Q42671915 |
| | Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. | Q43554604 |
| | Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers | Q43594287 |
| | Effects of subchronic lithium chloride treatment on G-protein subunits (Golf, Ggamma7) and adenylyl cyclase expressed specifically in the rat striatum | Q43786511 |
| | Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder | Q43961844 |
| | Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium | Q44264546 |
| | Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder | Q44334411 |
| | Attenuation of N-methyl-D-aspartate-mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers | Q44374041 |
| | Valproic acid down‐regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase‐1 and ‐2 in rat brain | Q44402831 |
| | A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 |
| | Genetic analysis of a functional GRIN2A promoter (GT)n repeat in bipolar disorder pedigrees in humans | Q44480132 |
| | Apoptosis of spinal cord neurons by preventing depletion nicotine attenuates arachidonic acid-induced of neurotrophic factors | Q44677435 |
| | Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide | Q44792337 |
| P433 | issue | 2 | |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 207-214 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Current molecular pharmacology | Q26842459 |
| P1476 | title | Mood-stabilizers target the brain arachidonic acid cascade | |
| P478 | volume | 2 | |